By Professor Michael Proinsias Farrell

Journal articles

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Black N; Chung S; Tisdale C; Fialho LS; Aramrattana A; Assanangkornchai S; Blaszczynski A; Bowden-Jones H; van den Brink W; Brown A; Brown QL; Cottler LB; Elsasser M; Ferri M; Florence M; Gueorguieva R; Hampton R; Hudson S; Kelly PJ; Lintzeris N; Murphy L; Nadkarni A; Neale J; Rosen D; Rumpf HJ; Rush B; Segal G; Shorter GW; Torrens M; Wait C; Young K; Farrell M, 2024, 'An International, Multidisciplinary Consensus Set of Patient-Centered Outcome Measures for Substance-Related and Addictive Disorders', Journal of Clinical Medicine, 13, http://dx.doi.org/10.3390/jcm13072154

Hall W; Darke S; Farrell M, 2024, 'Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?', Addiction, 119, pp. 786 - 787, http://dx.doi.org/10.1111/add.16416

Acheson LS; Clay S; McKetin R; Lintzeris N; Dunlop A; Brett J; Christmass M; Rodgers C; Shoptaw S; Farrell M; Ezard N; Siefried KJ, 2024, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', International Journal of Drug Policy, 126, http://dx.doi.org/10.1016/j.drugpo.2024.104383

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Nielsen S; Degenhardt L; Farrell M, 2024, 'Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence', International Journal of Drug Policy, 126, pp. 104359, http://dx.doi.org/10.1016/j.drugpo.2024.104359

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'A descriptive coronial study of heroin toxicity deaths in Australia, 2020–2022: Characteristics, toxicology and survival times', Addiction, 119, pp. 559 - 569, http://dx.doi.org/10.1111/add.16377

Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J, 2024, 'Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13817

Farnbach S; Foley C; Gates P; Seccull A; Henderson A; Zocco A; Farrell M; Shakeshaft A, 2024, 'Enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales, Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13843

Tran AD; Grebely J; Chambers M; Degenhardt L; Farrell M; Bajis S; Larance B, 2024, 'Health utility among people who regularly use opioids in Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13823

Xu W; Smith N; Ting R; Soh Q; Saeed U; Farrell M; Wright D; Li J; Waraich A; Gaborit L; Jabur A; Kalyanasundaram K; Ohis C; Foong C; Ong ; Siribaddana V; Raubenheimer K; Vu J; Ferguson L; Varghese C; Pockney P; Atherton K; Martin J; Banerjee A; Dudi-Venkata N; Lightfoot N; Ludbrook I; Peters L; Sara R; Watson D; Adeyeye A; Alvarez-Lozada LA; Atici SD; Buhavac M; Calini G; Elhadi M; Ioannidis O; Tepe MD; Nath U; Uzair A; Yang W; Zaidi F; Abdullah B; Ragab A; Daudu D; Benyani SV; Karthikeyan N; Mansour LT; Seow W; Tasi Z; Park M; Abdelmelek DE; Boussahel IFZ; Kaabache O; Lemdaoui N; Nebbar O; Rais M; Abdoun M; Kouicem AT; Bouaoud S; Bouchenak K; Saada H; Ouyahia A; Messai W; Choong ZS; Ting C; Larkin M; Fong PJ; Soh I; De Grandi A; Iftikhar H; Sinha A; Kapoor D; Chlebicka T; Singer D; Goddard K; Matthews L; Lin R; Chambers J; Chan J; Macnab B; Barker J; McKenzie M; Ferguson N; Juwaheer G; Walters C; Nguyen K; Liu D; Cabalag C; Lee J; Leow SHA; Ng SL; Ashraf H; Mulder F; Loo J; Proud D; Wong S; Zhou Y; Soh QR; Chye D, 2024, 'Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries', British Journal of Surgery, 111, http://dx.doi.org/10.1093/bjs/znad421

Acheson LS; Gordon C; McKetin R; Brett J; Christmass M; Rodgers C; Lintzeris N; Dunlop A; Farrell M; Shoptaw S; Ezard N; Siefried KJ, 2024, 'Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility Study', European Addiction Research, http://dx.doi.org/10.1159/000536328

Lawson S; Bryant J; Freund M; Dizon J; Haber PS; Shakeshaft A; Jefferies M; Farrell M, 2024, 'Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13833

Bharat C; Chidwick K; Gisev N; Farrell M; Ali R; Degenhardt L, 2024, 'Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104255

Macdonald C; Weatherburn D; Butler T; Albalawi O; Greenberg D; Farrell M, 2024, 'Who gets diverted into treatment? a study of defendants with psychosis', Psychiatry, Psychology and Law, 31, pp. 132 - 145, http://dx.doi.org/10.1080/13218719.2023.2175070

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'Differences in heroin overdose deaths in Australia by age, 2020-2022: Disease and estimated survival times.', Drug Alcohol Depend Rep, 10, pp. 100217, http://dx.doi.org/10.1016/j.dadr.2024.100217

Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Bonn M; Wheeler A; Grebely J; Farrell M; Hickman M; Hayward A; Degenhardt L, 2023, 'Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia', International Journal of Drug Policy, 122, http://dx.doi.org/10.1016/j.drugpo.2023.104218

Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J, 2023, 'Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review', The Lancet Global Health, 11, pp. e1885 - e1898, http://dx.doi.org/10.1016/S2214-109X(23)00461-8

Ratledge M; Del Rio E; Watson B; Said N; Rice N; Farrell M; Dewald E; Nikroo A; Clark D, 2023, 'Correcting Hohlraum Drive Asymmetry with Glow Discharge Polymerization Coated Capsule Shims', Fusion Science and Technology, 79, pp. 801 - 808, http://dx.doi.org/10.1080/15361055.2023.2210705

Dale K; Vargas N; Jara A; Marin E; Lovelace G; Langley N; Williams J; Reuter T; Kong C; Monton C; Alexander N; Farrell M; Sweet W, 2023, 'Fabricating Boron-Doped Nanowires­', Fusion Science and Technology, 79, pp. 870 - 878, http://dx.doi.org/10.1080/15361055.2023.2169547

Downing BC; Hickman M; Jones NR; Larney S; Sweeting MJ; Xu Y; Farrell M; Degenhardt L; Jones HE, 2023, 'Prevalence of opioid dependence in New South Wales, Australia, 2014–16: Indirect estimation from multiple data sources using a Bayesian approach', Addiction, 118, pp. 1994 - 2006, http://dx.doi.org/10.1111/add.16268

Bharat C; Webb P; Wilkinson Z; McKetin R; Grebely J; Farrell M; Holland A; Hickman M; Tran LT; Clark B; Peacock A; Darke S; Li JH; Degenhardt L, 2023, 'Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis', Addiction, 118, pp. 1624 - 1648, http://dx.doi.org/10.1111/add.16200

Havard A; Jones N; Bharat C; Gisev N; Pearson SA; Shakeshaft A; Farrell M; Degenhardt L, 2023, 'Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality', Drug and Alcohol Review, 42, pp. 1461 - 1471, http://dx.doi.org/10.1111/dar.13669

Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R, 2023, 'Perspectives and sentiments on contingency management from people who use methamphetamine', Drug and Alcohol Review, 42, pp. 1427 - 1437, http://dx.doi.org/10.1111/dar.13691

Darke S; Farrell M; Lappin J, 2023, 'Overdose and suicide are different phenomena among opioid users that require different clinical management', Australian and New Zealand Journal of Psychiatry, 57, pp. 1095 - 1100, http://dx.doi.org/10.1177/00048674231159298

Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M, 2023, 'Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies', The Lancet Psychiatry, 10, pp. 386 - 402, http://dx.doi.org/10.1016/S2215-0366(23)00095-0

Lappin JM; Darke S; Farrell M, 2023, 'Psychotogenic potential of prescribed drugs', Australian and New Zealand Journal of Psychiatry, 57, pp. 777 - 779, http://dx.doi.org/10.1177/00048674231174807

Wong RXY; Farrell M; Degenhardt L; Memedovic S; Harvey SB; Petrie K, 2023, 'Substance use among vocational trainees in Australia: differences between medical specialties', Internal Medicine Journal, 53, pp. 939 - 945, http://dx.doi.org/10.1111/imj.15729

Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A, 2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002

Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J, 2023, 'Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review', The Lancet Global Health, 11, pp. e659 - e672, http://dx.doi.org/10.1016/S2214-109X(23)00057-8

Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L, 2023, 'Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review', The Lancet Global Health, 11, pp. e673 - e683, http://dx.doi.org/10.1016/S2214-109X(23)00058-X

Saxby K; Ireland A; Ghijben P; Sweeney R; Sia KL; Chen E; Farrell M; McRobbie H; Courtney R; Petrie D, 2023, 'Household Composition and Smoking Behavior in a Prospective Longitudinal Australian Cohort', Nicotine and Tobacco Research, 25, pp. 859 - 866, http://dx.doi.org/10.1093/ntr/ntac270

Colledge-Frisby S; Jones N; Degenhardt L; Hickman M; Padmanathan P; Santo T; Farrell M; Gisev N, 2023, 'Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109851

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Hayllar J; Grebely J; Marshall AD, 2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998

McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O’Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ, 2023, 'A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland', Familial Cancer, 22, pp. 135 - 149, http://dx.doi.org/10.1007/s10689-022-00313-0

Yuen WS; Peacock A; Man N; Callinan S; Slade T; Farrell M; Mattick R; Livingston M; Peacock A, 2023, 'Age, period and cohort effects on alcohol-related risky behaviours in Australia from 2001 to 2016', Addiction, 118, pp. 438 - 448, http://dx.doi.org/10.1111/add.16061

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of cocaine-related completed suicide in Australia, 2000–2021', Drug and Alcohol Dependence, 244, http://dx.doi.org/10.1016/j.drugalcdep.2023.109803

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Clinical characteristics of fatal cocaine toxicity in Australia, 2000–2021', Drug and Alcohol Review, 42, pp. 582 - 591, http://dx.doi.org/10.1111/dar.13581

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959

Black E; Mammen K; Deacon RM; Ezard N; Mills L; Dunlop AJ; Montebello M; Reid D; Childs S; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Holmes J; Lintzeris N, 2023, 'Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019', Drug and Alcohol Review, 42, pp. 389 - 400, http://dx.doi.org/10.1111/dar.13588

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, 118, pp. 297 - 306, http://dx.doi.org/10.1111/add.16055

Darke S; Zahra E; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000–2021', Clinical Toxicology, 61, pp. 260 - 265, http://dx.doi.org/10.1080/15563650.2023.2184243

Darke S; Farrell M; Duflou J; Lappin J, 2023, 'Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications', Addiction, http://dx.doi.org/10.1111/add.16407

Howard BC; McRobbie H; Petrie D; Barker D; Mendelsohn C; Anderson J; Borland R; Naughton F; Tutka P; Zwar N; Boland VC; Aiken A; Shakeshaft A; Gartner C; Richmond RL; Hall W; Mattick RP; Farrell M; Courtney RJ, 2022, 'Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06644-8

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial', Drug and Alcohol Dependence, 241, pp. 109692, http://dx.doi.org/10.1016/j.drugalcdep.2022.109692

Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson SA; Dobbins T; Dunlop A; Mattick RP; Peacock A; Peacock A, 2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, 41, pp. 1577 - 1588, http://dx.doi.org/10.1111/dar.13529

Farrell M, 2022, 'From harm to hope or is it from harmful to hopeless?', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103845

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', PLoS ONE, 17, pp. e0275371, http://dx.doi.org/10.1371/journal.pone.0275371

Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, pp. 103788, http://dx.doi.org/10.1016/j.drugpo.2022.103788

Dewald EL; Clark DS; Casey DT; Khan SF; Mariscal D; Nicola PD; MacGowan BJ; Hartouni EP; Rubery MS; Choate C; Nikroo A; Smalyuk VA; Landen OL; Ratledge M; Fitzsimmons P; Farrell M; Mauldin M; Rice N, 2022, 'Compensating cylindrical Hohlraum mode 4 asymmetry via capsule thickness tailoring and effects on implosions', Physics of Plasmas, 29, http://dx.doi.org/10.1063/5.0100095

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548

Back to profile page